Login
Bakers lures partner from NRF
Baker McKenzie has appointed a new IPTech partner, who will be based in the firm’s Sydney practice.
Tony Zhang
Helen Macpherson has joined Bakers’ IPTech practice, specialising in intellectual property litigation and dispute resolution.
To continue reading the rest of this article, please log in.
Create free account to get unlimited news articles and more!
She brings over 15 years’ experience as an intellectual property specialist, holding extensive experience in advising clients on all types of intellectual property, including patents, trademarks, copyright, moral rights and confidential information.
Ms Macpherson joins Bakers from Norton Rose Fulbright. This comes after Herbert Smith Freehills nabbed a financial services regulatory partner from NRF and Minters welcomed a leading M&A partner to its transaction solutions team.
Baker McKenzie’s national managing partner, Anthony Foley, stated: “Helen comes to us with over 20 years’ experience, having built a market-leading reputation as a high-stakes IP litigator, with a particular focus on large-scale patent litigation. She is a welcome addition to our market-leading team in Sydney.”
Ms Macpherson’s practice focuses on a range of industries including the pharmaceutical, life sciences, telecommunications, consumer goods, manufacturing, finance, media and advertising industries.
Furthermore, she has a particular focus on patent litigation in the pharmaceutical and life sciences industries, and has been the lead litigator in a number of prominent Australian pharmaceutical patent cases.
According to Bakers, Ms Macpherson works across a number of industry sectors, advising clients including: healthcare in respect to pharmaceuticals, life sciences and medical devices; consumer goods and retail; agribusiness; and technology, media and telecommunications.
“We are very fortunate to have attracted someone of Helen’s calibre. She brings a wealth of experience in a broad range of IP litigation but particularly in the patent area where we have an existing capability both globally and locally,” Baker McKenzie’s head of IPTech in Australia, Andrew Stewart, stated.
“Helen’s skills and experience will assist to develop further the strength of that offering both in the pharma and technology areas. What stood out early on in our discussions with Helen [were] her professionalism and dedication to her clients – both highly desirable attributes.”
Ms Macpherson also publishes widely, and will continue to contribute to the public discourse in her areas of expertise.
In joining the firm, Ms Macpherson remarked: “I am excited to be joining the firm and its market-leading IPTech practice. I look forward to working with the firm’s high-calibre clients and having access to an unsurpassed global footprint.”
